Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Transneuronix Inc (AKA: Medtronic Transneuronix Inc)
Profile last edited on: 8/13/10      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1997
First Award
2003
Latest Award
2007
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

100 Stierli Court Suite 106
Mt Arlington, NJ 07856
   (973) 601-1950
   N/A
   www.transneuronix.com
Location: Single
Congr. District: 07
County: Morris

Public Profile

In June 2005, Transneuronix Inc was acquired by Medtronic. Transneuronix is a medical device company that is performing worldwide research and development in order to provide better therapeutic options for obesity and other disabling diseases. A large intellectual property portfolio has been developed and the company is currently conducting clinical trials of the Transcend® Implantable Gastric Stimulator (IGS®) for the treatment of obesit

Extent of SBIR involvement

User Avatar
Phase I Awards
2
Phase II Awards
1
Conversion Rate
50.00%
Phase I Dollars
$350,000
Phase II Dollars
$649,000
Total Awarded
$999,000

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
25-49

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2007 2 NIH $749,000
Project Title: Therapeutic Potential of Intestinal Pacing for Obesity
2004 1 NIH $250,000
Project Title: Dual-pulse electrical stimulation for gastroparesis

Key People / Management

  David Jenkins -- President

  Jiande Chen

Company News

There are no news available.